Inside a laboratory at Purdue University, a nozzle spray fires thousands of tiny, charged droplets at a slide of materials—and in the impact between solvent and sample, new drug compounds are born at room temperature, without catalysts, in seconds. This isn't science fiction; it's the result of research by Graham Cooks, Henry Bohn Hass Distinguished Professor of Chemistry at Purdue's College of Science, and his team at Aston Labs, who have transformed mass spectrometry from a tool for identifying compounds into a platform that actually synthesizes them.
The stakes of this breakthrough are enormous. Drug development typically takes 10 to 15 years—a timeline that stretches the patience of scientists, pharmaceutical companies, and desperate patients alike. Chemical reactions that form the backbone of medicine-making have historically required high temperatures, harsh conditions, and catalysts to proceed at workable speeds. Purdue's new method eliminates that friction. By harnessing the kinetic energy of fast-moving droplets in their automated DESI (desorption electrospray ionization) mass spectrometry system, Cooks' team has discovered that reactions happen rapidly and cleanly at room temperature, with no catalysts needed at all.
The system works elegantly. Samples are arranged on a high-density slide in a tight grid, and the DESI nozzle sprays them with a solvent containing charged droplets. When the spray impacts the material, it "lifts" component molecules—a process called desorption—and directs them into a tube that transports them to the mass spectrometer for analysis or synthesis. Because no sample preparation is required, no cleaning or purification needed, the system can process one sample per second. That translates to approximately 3,600 experiments per hour—a velocity that Cooks himself marvels at when he considers how traditional mass spectrometry platforms require minutes to analyze a single sample.
What makes this technology revolutionary is the platform's dual functionality. The DESI system can switch between two modes: analysis and synthesis. The only difference is the distance between the sample spot and the inlet of the instrument. This flexibility means researchers can not only rapidly screen materials but also perform novel chemical reactions in real time, producing compounds necessary for pharmaceutical and agricultural applications. The system is fully automated, with a robotic arm transferring samples between components and limiting human intervention—reducing errors and accelerating workflows even further.
The discovery that mass spectrometry, traditionally viewed as purely analytical, could become a synthetic tool represents a fundamental reimagining of what the technology can do. Cooks noted that the system can work with "dirty" materials, meaning samples can be collected directly from the field and reused for future experiments. This nondestructive approach opens pathways for exploring chemistry in ways previously impossible.
The implications ripple outward. When drug development can eat up 15 years of a scientist's career, anything that shortens that timeline matters profoundly. A method that accelerates pharmaceutical development by orders of magnitude—moving from minutes per sample to thousands of reactions per hour—could reshape how quickly life-changing treatments reach patients. Purdue's Office of Technology Commercialization has already applied for and received several patents through the U.S. Patent and Trademark Office, signaling that this research is poised to move from laboratory to real-world application. As the work was published in the Journal of the American Chemical Society, Cooks and his team are inviting the broader scientific community to imagine what becomes possible when speed and precision merge in the search for new medicines.